Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On April 1, 2024, we issued 2,659,102 shares of our Class A common stock to certain sellers of Modulus Therapeutics, Inc. (“Modulus”), valued at approximately $3.0 million, as consideration in connection with the acquisition by merger of Modulus, in a private placement transaction exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) of the Securities Act.
44
Table of Contents
On April 26, 2024, we issued a total of 4,692,086 shares of our Class A common stock to certain former equity holders of FGen AG, valued at approximately $4.3 million, in connection with the achievement of certain milestones, in a private placement transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.